Stocktoria
Oscar Health, Inc. OSCR
Oscar Health, Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $11.7B | $9.2B | $5.9B | $4.0B | $1.8B | $462.8M |
| SG&A expense | $2.0B | $1.8B | $1.4B | $1.3B | — | — |
| Operating income | -$396.4M | $57.3M | -$235.6M | -$589.9M | -$544.5M | -$402.3M |
| Interest expense | — | — | $24.6M | $22.6M | $4.7M | $3.5M |
| Income tax | $5.6M | $7.3M | $3.3M | -$523,000 | $846,000 | $1.0M |
| Net income | -$443.2M | $25.4M | -$270.7M | -$606.3M | -$572.6M | -$406.8M |
| EPS (diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-14.16 |
| Operating cash flow | $1.1B | $978.2M | -$272.2M | $380.3M | -$181.7M | $222.7M |
| Cash & equivalents | $2.8B | $1.5B | $1.9B | $1.6B | $1.1B | $826.3M |
| Total assets | $6.3B | $4.8B | $3.6B | $4.5B | $3.3B | $2.3B |
| Total liabilities | $5.3B | $3.8B | $2.8B | $3.6B | $1.9B | $1.8B |
| Shareholders' equity | $980.7M | $1.0B | $806.1M | $892.4M | $1.4B | -$1.3B |
Growth · year-over-year · Revenue CAGR 90.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | +27.5% | +56.5% | +47.9% | +115.6% | +297.3% | — |
| Net income growth | -1842.5% | — | — | — | — | — |
| EPS growth | -1790.0% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.